| Health / Medical Topics |
Lapuleucel-T
A cell-based vaccine targets tumors expressing the HER2/neu marker. HER-2/neu is a growth factor receptor, and its overexpression has been associated with a number of cancers including breast, ovarian, colon and lung cancers. APC8024 comprise of autologous antigen-presenting peripheral blood mononuclear cells (APCs) that have been exposed to HER2/neu protein and can be administered to the patient. These cells may stimulate an antitumor T-cell response to cancer cells expressing HER2/neu. (NCI Thesaurus)
YOU MAY ALSO LIKE
Human LAPTM4B wild-type allele is located in the vicinity of 8q22.1 and is approximately 146 kb in length. This allele, which encodes…
This gene may play a role in transport processes.
A plant whose seeds and root have been used in some cultures to treat certain medical problems. It may have antioxidant…
A drug used with another anticancer drug to treat breast cancer that is HER2 positive and has advanced or metastasized (spread to…
A drug used with another anticancer drug to treat breast cancer that is HER2 positive and has advanced or metastasized (spread to…
A surgical incision made in the wall of the abdomen.
